Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
63.09 USD | -3.66% |
|
+6.23% | +14.42% |
06-26 | HC Wainwright Adjusts ANI Pharmaceuticals Price Target to $94 From $87, Maintains Buy Rating | MT |
06-24 | Top Midday Gainers | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+14.42% | 1.22B | |
+55.95% | 819B | |
+43.27% | 638B | |
-6.98% | 351B | |
+19.08% | 329B | |
+9.05% | 298B | |
+17.09% | 242B | |
+2.62% | 225B | |
+13.18% | 217B | |
+8.91% | 168B |
- Stock Market
- Equities
- ANIP Stock
- News ANI Pharmaceuticals, Inc.
- ANI Pharmaceuticals to Acquire Alimera Sciences in $381 Million Deal